Safety of low doses of quetiapine when used for insomnia;La seguridad de dosis bajas de quetiapina cuando se utiliza para insomnio

Annals of Pharmacotherapy

Volumn 46, Issue 5, 2012, Pages 718-722

  Coe, Holly V ^a   Hong, Irene S ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Insomnia; Low dose; Quetiapine; Safety; Sleep; Subtherapeutic; Weight gain

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; QUETIAPINE;

AKATHISIA; DIABETES MELLITUS; DROWSINESS; DRUG FATALITY; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; HUMAN; HYPERLIPIDEMIA; INSOMNIA; LIVER TOXICITY; LOW DRUG DOSE; METABOLIC DISORDER; OBESITY; OFF LABEL DRUG USE; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; RESTLESS LEGS SYNDROME; REVIEW; SIDE EFFECT; SYSTEMATIC REVIEW; TREATMENT OUTCOME; WEIGHT GAIN; XEROSTOMIA;

ANTIPSYCHOTIC AGENTS; DIBENZOTHIAZEPINES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 84860991804     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1Q697     Document Type: Review

References (24)

1. Product information. Seroquel (quetiapine fumarate immediate-release tablets). Wilmington, DE: AstraZeneca, July 2011.
2. Product information. Seroquel XR (quetiapine fumarate extended-release tablets). Wilmington, DE: AstraZeneca, July 2011.
3. Philip NS, Mello K, Carpenter LL, Tyrka AR, Price LH. Patterns of que-tiapine use in psychiatric inpatients: an examination of off-label use. Ann Clin Psychiatry 2008;20:15-20. DOI 10.1080/10401230701866870
4. Dolder CR, McKinsey J. Quetiapine for sleep in patients with dementia. Consult Pharm 2010;25:676-679. DOI 10.4140/TCP.n.2010.676
5. Hartung DM, Wisdom J P, Pollack DA, et al. Patterns of atypical antipsy-chotic subtherapeutic dosing among Oregon Medicaid patients. J Clin Psychiatry 2008;69:1540-1547. DOI 10.4088/JCP.v69n1003
6. Wine JN, Sanda C, Caballero J. Effects of quetiapine on sleep in nonpsy-chiatric and psychiatric conditions. Ann Pharmacother 2009;43:707-713. DOI 10.1345/aph.1L320
7. Gugger JJ, Cassagnol M. Low-dose quetiapine is not a benign sedative-hypnotic agent. Am J Addict 2008;17:454-455. DOI 10.1080/10550490802266185
8. Keltner NL, Vance DE. Biological perspectives: incarcerated care and quetiapine abuse. Perspect Psychiatr Care 2008;44:202-206. DOI 10.1111/j.1744-6163.2008.00175.x
9. Pierre JM, Shnayder I, Wirshing DA, Wirshing WC. Intranasal quetiapine abuse. Am J Psychiatry 2004;16:1718. DOI 10.1176/appi.ajp.161.9.1718
10. Pinta ER, Taylor RE. Quetiapine addiction? Am J Psychiatry 2007;164: 174-175. DOI 10.1176/appi.ajp.164.1.174
11. Sansone RA, Sansone LA. Is seroquel developing an illicit reputation for misuse/abuse? Psychiatry 2010;7:13-16. DOI 10.1176/appi.ajp.164.1.174
12. Waters BM, Joshi KG. Intravenous quetiapine-cocaine use ("Q-ball"). Am J Psychiatry 2007;164:173-174. DOI 10.1176/appi.ajp.164.1.173-a
13. National Institutes of Health. State- of-the-science conference statement on manifestations and management of chronic insomnia in adults, 2005. http://consensus.nih.gov/2005/insomniastatement.htm (accessed 2011 Sept 7).
14. Schutte-Rodin S, Broch L, Buysee D, Dorsey C, Sateia M. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med 2008;4:487-504.
15. Wilson SJ, Nutt DJ, Alford C, et al. British Association for Psychophar-macology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders. J Psychopharmacol 2010; 24:1577-600. DOI 10.1177/0269881110379307
16. Maher AR, Maglione M, Bagley S, et al. Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis. JAMA 2011;306:1359-1369. DOI 10.1001/jama.2011.1360
17. Tassniyom K, Paholpak S, Tassniyom S, Kiewyoo J. Quetiapine for primary insomnia: a double blind, randomized controlled trial. J Med Assoc Thai 2010;93:729-734.
18. Wiegand MH, Landry F, Bruckner T, Pohl C, Vesely Z, Jahn T. Quetiapine in primary insomnia: a pilot study. Psychopharmacology 2008;196: 337-338. DOI 10.1007/s00213-007-0968-8
19. Cates ME, Jackson CW, Feldman JM, Stimmel AE, Woolley TW. Metabolic consequences of using low-dose quetiapine for insomnia in psychiatric patients. Community Ment Health J 2009;45:251-254. DOI 10.1007/s10597-009-9200-0
20. Williams SG, Alinejad NA, Williams JA, Cruess DF. Statistically significant increase in weight caused by low-dose quetiapine. Pharmacotherapy 2010;30:1011-1015. DOI 10.1592/phco.30.10.1011
21. Naharci MI, Karadurmus N, Demir O, Bozoglu E, Ak M, Doruk H. Fatal hepatotoxicity in an elderly patient receiving low-dose quetiapine. Am J Psychiatry 2011;168:212-213. DOI 10.1176/appi.ajp.2010.10091292
22. Pinninti NR, Mago R, Townsend J, Doghramji K. Periodic restless legs syndrome associated with quetiapine use: a case report. J Clin Psycho-pharmacol 2005;25:617-618. DOI 10.1176/appi.ajp.2010.10091292
23. Catalano G, Grace JW, Catalano MC, Morales MJ, Cruse LM. Acute akathisia associated with quetiapine use. Psychosomatics 2005;46:291-301. DOI 10.1176/appi.psy.46.4.291
24. Pasquini M, Speca A, Biondi M. Quetiapine for tamoxifen-induced insomnia in women with breast cancer. Psychosomatics 2009;50:159-161. DOI 10.1176/appi.psy.50.2.159